Cyclomics

Description

Cyclomics develops molecular diagnostics and DNA sequencing products including the CySeq consensus sequencing and liquid biopsy platform and the Epinn AI framework for tumour classification for clinicians and researchers.

Cyclomics is located in the Netherlands ecosystem.

Related

• Oxford Nanopore TechnologiesOxford Nanopore Technologies builds nanopore-based sequencing devices and workflows for research and education customers, providing…
• CimCureCimCure develops cancer vaccines using its proprietary iBoost conjugate technology to induce immune responses that target and destroy…
• AcytronixAcytronix provides PMED, a portable microstructured electrochemical device that rapidly isolates extracellular vesicles from biofluids…
• AltraTechAltraTech builds a multimodal molecular diagnostic platform and portable digital diagnostic device that detects and quantifies DNA, RNA,…
• Trained Therapeutix DiscoveryTrained Therapeutix Discovery develops nanobiologic therapeutics that regulate trained immunity for applications in cancer and organ…
• GlycanosticsGlycanostics develops non-invasive liquid biopsy cancer diagnostics, building antibody-coated magnetic particle tests that detect glycan…
• Hedera DxHedera Dx enables hospital laboratories to perform in-house NGS genomic profiling, offering FFPE, ctDNA (liquid biopsy) and RNA-only…
• GenDxGenDx provides NGS-based kits and software for HLA typing, chimerism monitoring, and KIR typing used in transplant diagnostics, combining…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…